Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 17, Issue 1, Pages 90-97Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.07620621
Keywords
second kidney transplantation; patient survival; target trial emulation; restricted mean survival time; kidney transplantation; waiting lists
Categories
Funding
- Vienna Science and Technology Fund [LS16-019]
- European Unions H2020 Marie Sklodowska-Curie Actions grant [795292]
- Marie Curie Actions (MSCA) [795292] Funding Source: Marie Curie Actions (MSCA)
Ask authors/readers for more resources
The study results indicate that second kidney transplantation is associated with longer survival time compared to remaining on the waiting list after 10 years of follow-up. However, this survival difference diminishes with longer waiting times after the loss of the first graft.
Background and objectives The median kidney transplant half-life is 10-15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer associated with a lower risk of mortality compared with waitlisted patients treated by dialysis. Therefore, we investigated the association of time on waiting list with patient survival in patients who received a second transplantation versus remaining on the waiting list. Design, setting, participants, & measurements In this retrospective study using target trial emulation, we analyzed data of 2346 patients from the Austrian Dialysis and Transplant Registry and Eurotransplant with a failed first graft, aged over 18 years, and waitlisted for a second kidney transplantation in Austria during the years 1980-2019. The differences in restricted mean survival time and hazard ratios for all-cause mortality comparing the treatment strategies retransplant versus remain waitlisted with maintenance dialysis are reported for different waiting times after first graft loss. Results Second kidney transplantation showed a longer restricted mean survival time at 10 years of follow-up compared with remaining on the waiting list (5.8 life months gained; 95% confidence interval, 0.9 to 11.1). This survival difference was diminished in patients with longer waiting time after loss of the first allograft; restricted mean survival time differences at 10 years were 8.0 (95% confidence interval, 1.9 to 14.0) and 0.1 life months gained (95%confidence interval,214.3 to 15.2) for patients with waiting time for retransplantation of < 1 and 8 years, respectively. Conclusions Second kidney transplant is associated with patient survival compared with remaining waitlisted and treatment by dialysis, but the survival difference diminishes with longer waiting time.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available